Financials Akeso, Inc.

Equities

9926

KYG0146B1032

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. 01:38:14 09/07/2025 pm IST 5-day change 1st Jan Change
109.80 HKD 0.00% Intraday chart for Akeso, Inc. +19.41% +80.89%

Projected Income Statement: Akeso, Inc.

Forecast Balance Sheet: Akeso, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 -2,492 -1,792 -225 1,425 1,026 221 -3,128 -4,080
Change - 28.09% 87.44% 733.33% -28% -78.46% -1,515.38% -30.43%
Announcement Date 31/03/21 30/03/22 15/03/23 18/03/24 30/03/25 - - -
1CNY in Million
Estimates

Cash Flow Forecast: Akeso, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 555.7 716.1 802.5 879.5 593.7 317.2 328.7 369.7
Change - 28.87% 12.06% 9.59% -32.49% -46.58% 3.64% 12.46%
Free Cash Flow (FCF) 1 -1,173 -1,717 -2,043 1,588 -1,121 -224.6 101.4 1,227
Change - -46.35% -18.96% 177.75% -170.6% 79.97% 145.15% 1,110.21%
Announcement Date 31/03/21 30/03/22 15/03/23 18/03/24 30/03/25 - - -
1CNY in Million
Estimates

Forecast Financial Ratios: Akeso, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) - -577.19% -146.29% 48.41% -17.15% 8.75% 24.1% 33.99%
EBIT Margin (%) - -598.89% -158.92% 45.26% -26.28% 2% 19.11% 30.39%
EBT Margin (%) - -557.62% -169.79% 42.92% -23.59% 1.94% 19.35% 30.49%
Net margin (%) - -476.42% -139.48% 44.81% -24.22% 1.56% 16.22% 25.28%
FCF margin (%) - -761.15% -243.88% 35.09% -52.8% -6.32% 1.88% 15.4%
FCF / Net Income (%) 99.7% 159.76% 174.85% 78.31% 217.94% -405.07% 11.62% 60.92%

Profitability

        
ROA -42.58% -24.82% -22.68% 27.64% -4.69% 0.93% 6.67% 13.72%
ROE -74.05% -33.86% -40.29% 55.36% -8.94% 0.7% 11.38% 21.7%

Financial Health

        
Leverage (Debt/EBITDA) - - - 0.65x -2.82x 0.71x - -
Debt / Free cash flow - - - 0.9x -0.91x -0.98x - -

Capital Intensity

        
CAPEX / Current Assets (%) - 317.39% 95.8% 19.43% 27.95% 8.93% 6.11% 4.64%
CAPEX / EBITDA (%) -43.06% -54.99% -65.49% 40.14% -163% 102.01% 25.34% 13.65%
CAPEX / FCF (%) -47.36% -41.7% -39.28% 55.37% -52.95% -141.2% 324.09% 30.12%

Items per share

        
Cash flow per share 1 -0.9822 -1.227 -1.504 2.946 -0.62 0.7113 1.133 2.538
Change - -24.93% -22.52% 295.91% -121.05% 214.73% 59.32% 123.93%
Dividend per Share 1 - - - - - - - 0.0403
Change - - - - - - - -
Book Value Per Share 1 5.065 3.87 3.195 5.601 8.007 7.696 8.69 11.15
Change - -23.59% -17.44% 75.29% 42.96% -3.88% 12.92% 28.32%
EPS 1 -1.65 -1.32 -1.42 2.42 -0.6 0.051 0.99 2.293
Change - 20% -7.58% 270.42% -124.79% 108.49% 1,842.36% 131.66%
Nbr of stocks (in thousands) 7,87,057 8,17,057 8,41,057 8,41,057 8,97,575 8,97,575 8,97,575 8,97,575
Announcement Date 31/03/21 30/03/22 15/03/23 18/03/24 30/03/25 - - -
1CNY
Estimates
2025 *2026 *
P/E ratio 1,970x 101x
PBR 13x 11.6x
EV / Sales 25.4x 16.2x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
100.43CNY
Average target price
96.14CNY
Spread / Average Target
-4.27%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Financials Akeso, Inc.